Gerard Clarke Selected Research

Messenger RNA (mRNA)

1/2021	Activin A and Acvr2b mRNA from Umbilical Cord Blood Are Not Reliable Markers of Mild or Moderate Neonatal Hypoxic-Ischemic Encephalopathy.
1/2021	Up-Regulation of Nfat5 mRNA and Fzd4 mRNA as a Marker of Poor Outcome in Neonatal Hypoxic-Ischemic Encephalopathy.
10/2018	Placental FKBP51 mediates a link between second trimester maternal anxiety and birthweight in female infants.
1/2012	Dynamic 5-HT2C receptor editing in a mouse model of obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard Clarke Research Topics

Disease

9	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2022 - 10/2008
8	Inflammation (Inflammations) 03/2022 - 01/2015
6	Schizophrenia (Dementia Praecox) 01/2022 - 05/2012
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2016
5	Obesity 01/2021 - 01/2012
4	Body Weight (Weight, Body) 01/2022 - 08/2014
4	Mental Disorders (Mental Disorder) 01/2021 - 04/2015
4	Brain Diseases (Brain Disorder) 01/2021 - 11/2004
4	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021 - 08/2015
3	Neoplasms (Cancer) 01/2022 - 04/2015
3	Anxiety Disorders (Anxiety Disorder) 01/2022 - 04/2015
3	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 03/2014
3	Hypoxia (Hypoxemia) 10/2021 - 12/2018
3	Treatment-Resistant Depressive Disorder 01/2021 - 04/2009
3	Mood Disorders (Mood Disorder) 01/2021 - 03/2007
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 03/2014
2	Cognitive Dysfunction 01/2022 - 10/2016
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 12/2014
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2016
2	Alcoholism (Alcohol Abuse) 01/2021 - 05/2019
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 03/2014
2	Asphyxia (Suffocation) 01/2021 - 01/2019
2	Neuroinflammatory Diseases 10/2020 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 06/2019
2	Hypertension (High Blood Pressure) 09/2020 - 12/2018
2	Pain (Aches) 01/2020 - 02/2014
2	Nervous System Diseases (Neurological Disorders) 10/2016 - 04/2015
2	Bacterial Infections (Bacterial Infection) 02/2014 - 01/2014
1	Sepsis (Septicemia) 05/2022
1	Endotoxemia 05/2022
1	Hypothermia 05/2022
1	Microsatellite Instability 01/2022
1	Social Phobia 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Feeding and Eating Disorders (Eating Disorder) 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Overweight 01/2020

Drug/Important Bio-Agent (IBA)

13	Tryptophan (L-Tryptophan)FDA Link 05/2022 - 01/2009
12	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2009
8	Serotonin (5 Hydroxytryptamine)IBA 06/2022 - 01/2012
8	KynurenineIBA 05/2022 - 01/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2014
4	CytokinesIBA 05/2022 - 10/2008
4	Antidepressive Agents (Antidepressants)IBA 03/2022 - 03/2014
4	PrebioticsIBA 01/2022 - 10/2019
4	Pharmaceutical PreparationsIBA 01/2022 - 10/2016
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2012
4	Biological ProductsIBA 01/2021 - 05/2016
4	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2015
3	Neurotransmitter Agents (Neurotransmitter)IBA 05/2022 - 03/2007
2	Dopamine (Intropin)FDA LinkGeneric 05/2022 - 10/2012
2	Phenobarbital (Luminal)FDA Link 01/2022 - 11/2004
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 10/2017
2	salicylhydroxamic acid (SHAM)IBA 10/2021 - 12/2018
2	XanthinesIBA 01/2021 - 05/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 05/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 05/2019
2	Nicotine FDA Link 01/2021 - 05/2019
2	Opioid Analgesics (Opioids)IBA 01/2021 - 05/2019
2	Volatile Fatty AcidsIBA 09/2020 - 10/2019
2	Amino Acids FDA Link 01/2020 - 03/2007
2	EnzymesIBA 01/2019 - 10/2012
2	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 05/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2012
2	Cholinergic Agents (Cholinergics)IBA 04/2015 - 10/2008
1	LipopolysaccharidesIBA 05/2022
1	B7-H1 AntigenIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	acetovanillone (apocynin)IBA 10/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Drinking WaterIBA 10/2021
1	Hallucinogens (Psychedelics)IBA 01/2021
1	Kynurenic Acid (Kynurenate)IBA 01/2021
1	3-hydroxykynurenineIBA 01/2021
1	Quinolinic AcidIBA 01/2021
1	activin AIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Growth Differentiation Factor 5IBA 01/2021
1	ResveratrolIBA 10/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2012
2	Cesarean Section (Caesarean Section) 01/2022 - 05/2016
2	Traction 10/2019 - 01/2019
1	Punctures 05/2022
1	Ligation 05/2022
1	Immunotherapy 01/2022
1	Ketogenic Diet 01/2022
1	Bariatric Surgery 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Caloric Restriction 01/2022